Literature DB >> 16271550

Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings.

Jody H Hershey1, Laurie Schowalter, Stephanie B C Bailey.   

Abstract

Hepatitis A and B vaccinations can and should be integrated into public health settings that serve adults at high risk for infection (e.g., sexually transmitted disease and/or human immunodeficiency virus clinics, criminal justice settings), and a policy of universal immunization may be the best way to accomplish this goal in these settings. Although hepatitis vaccines should be given to all susceptible persons at risk, many opportunities to vaccinate adults at high risk are missed, and there are several barriers and challenges to vaccination of adults. These challenges and barriers can be overcome. Successful integration of hepatitis vaccination for adults into existing public health services and clinics has been accomplished across the United States at both state and local levels. Additional funds must be provided for the infrastructure and purchase of vaccines for adults in these settings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271550     DOI: 10.1016/j.amjmed.2005.07.028

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Donald Calsyn; Don Alderson; Kathlene Tracy; Patrick McAuliffe; Cheryl Smith; John Rotrosen
Journal:  J Subst Abuse Treat       Date:  2011-10-27

2.  Expansion of adult hepatitis A and B vaccination in STD clinics and other settings in New York State.

Authors:  Elizabeth J Herlihy; Susan J Klein; Martha L Newcomb; Debra S Blog; Guthrie S Birkhead
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Factors associated to duration of hepatitis a outbreaks: implications for control.

Authors:  Nuria Torner; Sonia Broner; Ana Martinez; Cecilia Tortajada; Patricia Garcia de Olalla; Irene Barrabeig; MariaRosa Sala; Neus Camps; Sofia Minguell; Josep Alvarez; Gloria Ferrús; Roser Torra; Pere Godoy; Angela Dominguez
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.